News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284 Results
Type
Article (44)
Company Profile (1)
Press Release (239)
Section
Business (117)
Deals (16)
Drug Development (37)
Job Trends (26)
News (146)
Policy (2)
Tag
Alliances (18)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (23)
Brain cancer (1)
Breast cancer (16)
Cancer (27)
CDC (1)
Clinical research (30)
Collaboration (2)
COVID-19 (2)
C-suite (1)
Cystic fibrosis (1)
Data (14)
Earnings (45)
Events (75)
Executive appointments (1)
FDA (6)
Funding (1)
Government (2)
Guidances (3)
Healthcare (5)
Immunology and inflammation (1)
Infectious disease (2)
IPO (12)
Job creations (1)
Layoffs (2)
Lung cancer (1)
Lymphoma (4)
Medical device (1)
Medtech (1)
Mergers & acquisitions (4)
Metabolic disorders (1)
Neurodegenerative disease (1)
Neuroscience (4)
NextGen: Class of 2025 (4)
Now hiring (1)
Obesity (1)
Parkinson's disease (4)
Patient recruitment (1)
People (58)
Pharmaceutical (1)
Phase I (18)
Phase II (12)
Phase III (8)
Pipeline (4)
Policy (1)
Preclinical (12)
Prostate cancer (3)
Radiopharmaceuticals (1)
Rare diseases (2)
Regulatory (3)
Series B (1)
Startups (11)
The Weekly (1)
Vaccines (1)
Venture capital (1)
Date
Last 7 days (2)
Last 30 days (7)
Last 365 days (52)
2025 (45)
2024 (44)
2023 (35)
2022 (34)
2021 (33)
2020 (31)
2019 (21)
2018 (12)
2017 (9)
2016 (8)
2015 (7)
2014 (4)
2013 (1)
Location
Asia (1)
California (1)
Canada (1)
Connecticut (40)
Europe (13)
Indiana (1)
Massachusetts (3)
New York (10)
North Carolina (1)
Northern California (1)
Pennsylvania (1)
Rhode Island (1)
United States (55)
284 Results for "arvinas".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025
October 29, 2025
·
1 min read
Press Releases
Arvinas to Participate in Upcoming September 2025 Investor Conferences
August 29, 2025
·
1 min read
Press Releases
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
September 18, 2025
·
12 min read
Press Releases
Arvinas to Present Data from the Vepdegestrant Clinical Development Program at the 2025 European Society for Medical Oncology (ESMO) Congress
October 13, 2025
·
6 min read
Press Releases
Arvinas to Present Preclinical Data for ARV-806, a PROTAC KRAS G12D Degrader, at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 22, 2025
·
4 min read
Press Releases
Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 6, 2025
·
23 min read
Press Releases
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
October 1, 2025
·
4 min read
Press Releases
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan
July 10, 2025
·
5 min read
Press Releases
Arvinas to Report Second Quarter 2025 Financial Results on August 6, 2025
July 31, 2025
·
1 min read
Press Releases
Arvinas Presents Preclinical Data for ARV-806 Demonstrating Robust and Differentiated Activity in Models of KRAS G12D-mutated Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 27, 2025
·
7 min read
1 of 29
Next
